DelveInsight’s Complement 3 Glomerulopathy Market Insights report includes a comprehensive understanding of current treatment practices, emerging complement 3 glomerulopathy drugs, market share of ...
MedPage Today on MSN
Novel Complement-Targeting Agent Shows Benefit in Myasthenia Gravis
The investigational complement-targeting agent claseprubart was safe and led to significant improvements in generalized ...
MedPage Today on MSN
Myasthenia Gravis Complement Inhibitor Meets Primary Endpoint in Phase III Trial
Investigational gefurulimab met its primary efficacy endpoint in adults with anti-acetylcholine receptor (AChR) ...
11d
Who is Ryan Rollins? The Bucks might have found a breakout star to complement Giannis Antetokounmpo
Following Damian Lillard's exit, the Bucks were in desperate need of a lead guard. Enter the second-round pick out of Toledo ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback